VIRGINIA RETIREMENT SYSTEMS ET Al Invests $1.46 Million in Bruker Corporation $BRKR

VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new position in Bruker Corporation (NASDAQ:BRKR) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 24,200 shares of the medical research company’s stock, valued at approximately $1,456,000.

Several other large investors also recently added to or reduced their stakes in the business. Los Angeles Capital Management LLC purchased a new stake in Bruker during the fourth quarter valued at approximately $26,000. Global Retirement Partners LLC purchased a new position in shares of Bruker during the 2nd quarter worth $38,000. Parallel Advisors LLC grew its position in shares of Bruker by 121.0% during the 4th quarter. Parallel Advisors LLC now owns 875 shares of the medical research company’s stock valued at $41,000 after acquiring an additional 479 shares during the period. Allworth Financial LP grew its position in shares of Bruker by 40.6% during the 3rd quarter. Allworth Financial LP now owns 890 shares of the medical research company’s stock valued at $29,000 after acquiring an additional 257 shares during the period. Finally, Essential Partners LLC purchased a new stake in shares of Bruker in the 1st quarter worth $36,000. 79.52% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

BRKR has been the topic of several analyst reports. Zacks Research downgraded Bruker from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, September 2nd. Wolfe Research began coverage on Bruker in a research note on Monday, June 1st. They issued a “peer perform” rating on the stock. UBS Group initiated coverage on Bruker in a research report on Wednesday. They set a “neutral” rating and a $65.00 price objective on the stock. Barclays boosted their price objective on Bruker from $53.00 to $60.00 and gave the company an “overweight” rating in a research note on Wednesday, June 24th. Finally, JPMorgan Chase & Co. raised their target price on shares of Bruker from $55.00 to $65.00 and gave the stock an “overweight” rating in a research note on Monday, June 8th. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, five have given a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $57.00.

Bruker Stock Down 0.2%

NASDAQ BRKR opened at $53.43 on Friday. Bruker Corporation has a 12 month low of $30.09 and a 12 month high of $65.30. The company has a current ratio of 1.85, a quick ratio of 0.92 and a debt-to-equity ratio of 0.76. The stock has a market cap of $8.14 billion, a PE ratio of -76.33, a P/E/G ratio of 1.63 and a beta of 1.26. The stock’s 50 day moving average is $58.25 and its 200 day moving average is $49.25.

Bruker (NASDAQ:BRKR) last announced its quarterly earnings results on Tuesday, August 4th. The medical research company reported $0.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.38 by $0.11. The company had revenue of $838.50 million for the quarter, compared to the consensus estimate of $853.57 million. Bruker had a negative net margin of 2.35% and a positive return on equity of 12.47%. Bruker’s revenue for the quarter was up 5.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.32 EPS. Bruker has set its FY 2026 guidance at 2.100-2.150 EPS. Research analysts predict that Bruker Corporation will post 2.12 EPS for the current fiscal year.

Bruker Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 7th. Stockholders of record on Monday, September 21st will be issued a $0.05 dividend. This represents a $0.20 annualized dividend and a dividend yield of 0.4%. The ex-dividend date of this dividend is Monday, September 21st. Bruker’s payout ratio is -28.57%.

Bruker Company Profile

Bruker Corporation develops and manufactures scientific instruments, analytical systems and software used to study the chemical, physical and biological properties of materials. Its customers include universities, pharmaceutical and biotechnology companies, industrial manufacturers, hospitals, government laboratories and other research organizations.

The company’s product portfolio includes nuclear magnetic resonance and electron paramagnetic resonance systems, mass spectrometers, X-ray analysis instruments, optical and molecular spectroscopy systems, microscopy and nanoanalysis tools, and instruments for microbiology and spatial biology.